The enrichment of CD138+ cells by Ferrofluid (CD138-FF) technology was developed as a diagnostic tool (CellSearch) to isolate circulating tumor cells in multiple myeloma patients using 4-6 mL of fresh blood (13). This evidence concerns the gene SDC1 and neoplasm.